Safety and Efficacy of Solithromycin in Adolescents and Children With Community-Acquired Bacterial Pneumonia
Status:
Terminated
Trial end date:
2018-03-21
Target enrollment:
Participant gender:
Summary
This is a phase 2/3, randomized, open-label, active control, multi-center study to assess the
safety and efficacy of solithromycin in children and adolescents with community-acquired
bacterial pneumonia (CABP).
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Cempra Inc Melinta Therapeutics, Inc.
Collaborator:
Biomedical Advanced Research and Development Authority